Skip to main content

Cancer Biomarkers

Promotes research to identify, develop, and validate biological markers for early cancer detection, risk prediction, and prevention. Supports development of collaborative databases and informatics systems, advancement of new technologies, and refinement of existing technologies.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Evans Williams, Felicia, M.B.A. felicia.evanslong@nih.gov 240-276-5076	5E636	Program Analyst \| Cancer Biomarkers
	Fu, Sidney, M.D. sidney.fu@nih.gov 240-276-6669	5E134	Program Officer \| Cancer Biomarkers
	Hodges, Nicholas, Ph.D. nick.hodges@nih.gov 240-276-7844	5E616	Program Officer \| Cancer Biomarkers
	Kohaar, Indu, Ph.D., M.Phil., M.Sc. indu.kohaar@nih.gov 240-620-0875	5E612	Program Officer \| Cancer Biomarkers
	Krueger, Karl, Ph.D. [V] karl.krueger@nih.gov		Volunteer \| Cancer Biomarkers
	Marquez, Guillermo, Ph.D. guillermo.marquez@nih.gov 240-276-7035	5E132	Program Officer \| Cancer Biomarkers
	Orr, Susan susan.orr@nih.gov 240-276-5001	5E626	Program Support Assistant \| Cancer Biomarkers
	Patriotis, Christos, Ph.D., M.Sc. christos.patriotis@nih.gov 240-276-7134	5E614	Deputy Chief \| Cancer Biomarkers
	Petruzzelli, Angie angie.petruzzelli@nih.gov 240-276-5076	5E624	Program Support Assistant \| Cancer Biomarkers
	Srivastava, Sudhir, Ph.D., M.P.H. sudhir.srivastava@nih.gov 240-276-7028	5E136	Chief \| Cancer Biomarkers
	Villanueva, Juan Miguel juan.villanueva@nih.gov	5E630	Program Analyst \| Cancer Biomarkers
	Wang, Wendy, Ph.D., M.Sc. wendy.wang@nih.gov 240-276-7117	5E566	Program Officer \| Cancer Biomarkers
	Young, Matthew, Ph.D. matthew.young@nih.gov 240-276-5846	5E610	Program Officer \| Cancer Biomarkers

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Salipante, Stephen J	University Of Washington United States	Efficient, cost-effective, and ultrasensitive sequencing of somatic mutations and methylation	1R33CA302385-01	Nicholas Hodges, Ph.D.
Salkowski, Lonie	University Of Wisconsin-Madison United States	Defining and Optimizing Critical Interpretation Skills in Screening Mammography to Improve Cancer Detection	5R37CA262110-04	Guillermo Marquez, Ph.D.
Salman, Emad	Florida Assn Of Pediatric Tumor Prog United States	The Florida Pediatric NCORP: NCI Community Oncology Research Program.	3UG1CA189973-11S1	Vanessa A. White, M.P.H.
Salvemini, Daniela	Saint Louis University United States	Fingolimod and Ozanimod for the treatment and prevention of chemobrain	5R01CA261979-04	Rachel Altshuler, Ph.D.
Sanchez, Eduardo Vilar	University Of Tx Md Anderson Can Ctr United States	Cancer Immune-Interception for Lynch Syndrome	5R01CA257375-05	Asad Umar, D.V.M., Ph.D.
Sanchez, Eduardo Vilar	University Of Tx Md Anderson Can Ctr United States	Cancer Immune-Interception in a Spontaneous Non-Human Primate Model of Lynch Syndrome	5R01CA260761-04	Asad Umar, D.V.M., Ph.D.
Sanchez, Eduardo Vilar	University Of Tx Md Anderson Can Ctr United States	iCAN PREVENT: MD Anderson International Cancer Prevention Clinical Trials Consortium	2UG1CA242609-07	Donald Johnsey
Sanda, Martin G	Emory University United States	Prostate Cancer Biomarker and Imaging Validation Alliance: Emory University, University of Alabama Birmingham, and University of Texas Southwestern	5U01CA113913-18	Indu Kohaar, Ph.D., M.Phil., M.Sc.
Sands, Stephen Alan	Sloan-Kettering Inst Can Research United States	Prospective international phase-III study to improve neurocognitive outcomes in young children with low-risk medulloblastoma (YCMB-LR)	5R01CA283045-02	Marjorie Perloff, M.D.
Santomasso, Bianca Denise	Sloan-Kettering Inst Can Research United States	Comprehensive Molecular and Clinical Characterization of Acute and Chronic Neurotoxicity Following CAR-T Cell Therapy	5R01CA293922-02	Monica Epstein, B.S.N., RN, OCN
Santos-Reyes, Luis Javier	Comprehensive Cancer Center/ Univ/Pr United States	Puerto Rico NCI Community Oncology Research Program (Puerto Rico NCORP)	3UG1CA189862-11S1	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Saphner, Thomas J	Aurora Health Care, Inc. United States	Aurora NCORP Community Site	3UG1CA190140-11S1	Vanessa A. White, M.P.H.
Schallenkamp, John M.	Montana Cancer Consortium United States	Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming	3UG1CA189872-11S1	Vanessa A. White, M.P.H.
Schaverien, Mark V	University Of Tx Md Anderson Can Ctr United States	Lymphedema Prevention Through Immediate Lymphatic Reconstruction	5R01CA292908-02	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Schedin, Pepper J	Oregon Health & Science University United States	NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention	5R01CA169175-11	Brandy Heckman-Stoddard, Ph.D., M.P.H.